Earnings History Data for Pulmatrix, Inc. (PULM) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Pulmatrix, Inc.
Pulmatrix, Inc. is a biopharmaceutical company which is engaged in developing inhaled therapies for serious pulmonary disease. The Company's proprietary product pipeline includes PUR1900, an inhaled anti-fungal for cystic fibrosis, PUR0200, a branded generic for chronic obstructive pulmonary disease which are in different clinical stage. Its technology platform consists of iSPERSE. Pulmatrix, Inc., formerly known as Ruthigen, Inc., is based in Lexington, MA.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10-08-2023 | PM | PULM | Pulmatrix | 10.00 | -1.04 | -1.23 | 0.00 | Pulmatrix GAAP EPS of -$1.04, revenue of $1.84M [8/10/2023 10:32 AM] |
2.58 | -0.05 (-1.90%) |
0.0 | 0.0 (0.00%) |
2.52 - 6.10 | 17,112 | 20,000 | 0 | ||
30-03-2023 | PM | PULM | Pulmatrix | 11.00 | -1.14 | -1.44 | 0.00 | Pulmatrix GAAP EPS of -$5.46, revenue of $6.1M [3/30/2023 9:58 AM] |
2.84 | -0.03 (-1.05%) |
0.0 | 0.0 (0.00%) |
2.77 - 7.50 | 31,716 | 20,000 | 0 | ||
10-11-2022 | PM | 9:05 AM ET (Nov 10) |
PULM | Pulmatrix, Inc. | 12.01 | -1.45 | -1.51 | -1.80 | Pulmatrix GAAP EPS of -$1.45 beats by $0.06, revenue of $1.87M beats by $0.71M [11/10/2022 9:12 AM] |
3.67 | 0.11 (3.08%) |
3.69 | 0.13 (3.64%) |
3.16 - 17.20 | 14,957 | 20,000 | 101 | |
08-08-2022 | PM | PULM | Pulmatrix | 18.00 | -1.36 | -1.51 | 0.00 | Pulmatrix GAAP EPS of -$1.36 beats by $0.15, revenue of $1.33M beats by $0.17M [8/8/2022 9:15 AM] |
5.22 | 0.11 (2.15%) |
0.0 | 0.0 (0.00%) |
4.03 - 20.80 | 167,342 | 240,000 | 0 | ||
10-11-2021 | AH | PULM | Pulmatrix | 45.00 | -0.09 | -0.07 | 0.00 | Pulmatrix EPS misses by $0.08, misses on revenue [11/10/2021 4:59 PM] |
0.7888 | -0.04 (-4.63%) |
0.80 | -0.03 (-3.28%) |
0.67 - 3.04 | 363,432 | 1,600,000 | 4,418 | ||
10-08-2021 | PM | Before the open (Aug 10) |
PULM | Pulmatrix, Inc. | 47.00 | -0.07 | -0.09 | 0.00 | Pulmatrix EPS beats by $0.02, beats on revenue [8/10/2021 9:14 AM] |
0.8121 | -0.01 (-0.65%) |
0.81 | -0.01 (-0.91%) |
0.78 - 3.04 | 250,905 | 370,000 | 2,285 | |
11-05-2021 | AH | After the close (May 11) |
PULM | Pulmatrix, Inc. | 50.00 | -0.09 | -0.10 | 0.00 | Pulmatrix EPS beats by $0.01 [5/11/2021 4:41 PM] |
0.86 | -0.04 (-4.76%) |
0.91 | 0.01 (0.76%) |
0.82 - 3.04 | 587,437 | 810,000 | 2,010 | |
23-03-2021 | PM | 9:00 AM ET (Mar 23) |
PULM | Pulmatrix, Inc. | 52.00 | -0.05 | -0.19 | 0.00 | Pulmatrix EPS beats by $0.15, beats on revenue [3/23/2021 9:33 AM] |
1.38 | -0.10 (-6.91%) |
0.0 | 0.0 (0.00%) |
0.93 - 3.04 | 1,792,377 | 1,700,000 | 0 | |
07-08-2020 | PM | PULM | Pulmatrix, Inc. | 32.78 | -0.05 | -0.38 | -0.07 | Pulmatrix EPS beats by $0.33 [8/7/2020 9:09 AM] |
1.30 | -0.02 (-1.14%) |
1.31 | 0.0 (0.00%) |
0.61 - 2.06 | 416,751 | 747,149 | 15,136 | ||
|